Secondary brain injury after aneurysmal subarachnoid haemorrhage: more than vasospasm

Comment

Alejandro A Rabinstein. Lancet Neurol. 2011 Jul.

. 2011 Jul;10(7):593-5.

doi: 10.1016/S1474-4422(11)70122-3. Epub 2011 Jun 2.

No abstract available

Comment on

Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage.
Rinkel GJ, Algra A. Rinkel GJ, et al. Lancet Neurol. 2011 Apr;10(4):349-56. doi: 10.1016/S1474-4422(11)70017-5. Lancet Neurol. 2011. PMID: 21435599 Review.
Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N. Macdonald RL, et al. Lancet Neurol. 2011 Jul;10(7):618-25. doi: 10.1016/S1474-4422(11)70108-9. Epub 2011 Jun 2. Lancet Neurol. 2011. PMID: 21640651 Clinical Trial.